KORU Medical Systems (KRMD) EV to EBITDA (2010 - 2026)

KORU Medical Systems (KRMD) has reported EV to EBITDA for 12 consecutive years, with 295.9 the latest figure, recorded in Q2 2026.

• On a quarterly basis, EV to EBITDA rose 158.75% year-over-year to 295.9 in Q2 2026; TTM through Jun 2026 was 112.25, a 229.54% decrease from a year earlier, with the FY2025 full-year figure at 87.65, down 237.62% from the prior year.
• EV to EBITDA was 295.9 for Q2 2026 at KORU Medical Systems, up from 220.24 in the prior quarter.
• Over five years, EV to EBITDA peaked at 295.9 in Q2 2026 and troughed at 503.64 in Q2 2025.
• A 5-year average of 108.22 and a median of 66.8 in 2023 frame the typical range for EV to EBITDA.
• Across the five-year window, EV to EBITDA tumbled 352.31% in 2025 and soared 158.75% in 2026, its largest moves.
• Over 5 years, EV to EBITDA stood at 57.66 in 2022, then advanced by 20.76% to 45.69 in 2023, then plunged by 130.43% to 105.28 in 2024, then slumped by 352.31% to 476.22 in 2025, then surged by 162.13% to 295.9 in 2026.
• The last three EV to EBITDA figures came in at 295.9 (Q2 2026), 220.24 (Q1 2026), and 476.22 (Q4 2025), per Business Quant data.